Home › Funds › Kalehua Capital Management LLC › MLTX

Kalehua Capital Management LLC position in MLTX

MOONLAKE IMMUNOTHERAPEUTICS · Health Care

Kalehua Capital Management LLC reported holding 175,734 shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS) in its Q2 2026 13F filing — a position valued at US$3.4M, representing 1.97% of its reported portfolio and ranking #18 among its reported holdings. Kalehua Capital Management LLC has disclosed MLTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)175.73K sh
Reported value held$3.42M
Portfolio Weight1.97%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Kalehua Capital Management LLC's MLTX position evolved

Kalehua Capital Management LLC first disclosed a stake in MLTX in Q4 2025 at 175,734 shares (US$2.3M). The position peaked in Q2 2026 at 175,734 shares, worth US$3.4M. Across 3 filings, Kalehua Capital Management LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 175,734 shares valued at US$3.4M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 175.73K $2.32M New
Q1 2026 175.73K $3.28M Hold
Q2 2026 175.73K $3.42M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MLTX and 13F data

MLTX (MOONLAKE IMMUNOTHERAPEUTICS) is a Health Care company. 30 other funds we track also report a position in MLTX — the largest reported positions include BVF INC/IL (US$311.5M), Deep Track Capital, LP (US$136.3M), Cormorant Asset Management, LP (US$62.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MLTX

All MLTX fund holders →

FAQ

How long has Kalehua Capital Management LLC held MLTX?

Kalehua Capital Management LLC has disclosed MLTX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Kalehua Capital Management LLC's current position in MLTX?

As of Q2 2026, Kalehua Capital Management LLC holds 175.73K shares of MLTX (MOONLAKE IMMUNOTHERAPEUTICS), valued at $3.42M, representing 1.97% of its reported portfolio and ranking #18.

Has Kalehua Capital Management LLC been buying or selling MLTX?

In the latest 13F filing (Q2 2026), Kalehua Capital Management LLC held unchanged its position in MLTX. The position peaked in Q2 2026 at 175.73K shares.

Which other funds hold MLTX?

Other major institutional holders of MLTX include BVF INC/IL, Deep Track Capital, LP, Cormorant Asset Management, LP, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.